H. San Pedro de Alcántara

Cáceres 10003

0 studies enrolling now · 2 studies all time

What they study most

Epithelial Ovarian Cancer, Fallopian Tube Cancer, HER-2 Positive Breast Cancer, Metastatic Neoplasm, Peritoneal Cancer

Studies at this site

• A Study of Mirvetuximab Soravtansine vs. Investigator's Choice (IC) of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha (FRα) Expression — Completed
• Margetuximab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy in the Treatment of HER2+ Metastatic Breast Cancer — Completed